BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  German Federal Ministry of Education and Research to Fund the CytoSorb Endocarditis REMOVE Trial

  The study is expected to begin in early 2018.

  December 11, 2017

   · 

  6 min read
• IntelGenx Receives USPTO Notice of Allowance for Montelukast Orange Book Eligible Patent

  IntelGenx announced that the United States Patent and Trademark Office has granted a Notice of Allowance for US Patent Application 15/299,054,

  December 11, 2017

   · 

  4 min read
• Novoheart Profiled on CBC’s Flagship News Program ‘The National’

  Novoheart announce that an in-depth feature on the company and its technology was broadcast on Friday, December 8th on CBC News, Canada’s largest news broadcaster.

  December 11, 2017

   · 

  3 min read
• Trillium Therapeutics Provides Update on Its TTI-621 Program at the American Society of Hematology 59th Annual Meeting

  Trillium Therapeutics announced today that new clinical data from ongoing Phase 1 a/b trials for its CD47-blocking agent, TTI-621 (SIRPa-IgG1 Fc), were presented at the American Society of Hematology 59th Annual Meeting, December 9-12, in Atlanta.

  December 11, 2017

   · 

  8 min read
• Drug Development

  PharmaMar Presents Positive Results of the Pivotal Phase III Trial With Plitidepsin in Multiple Myeloma During the ASH Meeting

  With regards to overall survival, a statistically significantly superior increase in the plitidepsin plus dexamethasone arm was observed according to the two-stage Latimer et al method.

  December 11, 2017

   · 

  7 min read
• Business

  Bone Therapeutics And Cellthera Pharma Announce Intention to Collaborate, and Bone Therapeutics Provides Overview of Its Pipeline

  Pharmstandard International S.A., the investment arm of a group of companies which includes Cellthera, has also expressed its intention to participate in a potential future capital increase by Bone Therapeutics.

  December 11, 2017

   · 

  8 min read
• BioCapital

  Processa Pharma Announces Reverse Stock Split and Launches New Website

  Processa formed from the merger of Promet Therapeutics and Heatwurx, is an emerging clinical stage biotech company focused on the development of drugs for the treatment of high unmet medical need conditions.

  December 11, 2017

   · 

  3 min read
• Biotech Beach

  FDA Approves Investigational Device Exemption for SetPoint Bioelectronic Therapy Clinical Study in Rheumatoid Arthritis

  SetPoint has received Investigational Device Exemption (IDE) approval from the FDA to initiate a pilot trial in the U.S. for patients with drug refractory rheumatoid arthritis (RA).

  December 11, 2017

   · 

  3 min read
• Biotech Beach

  Scientist.com Celebrates 10th Anniversary as Outsourcing Marketplace Leader

  Scientist.com now has more than 2,250 pre-signed global suppliers in its network, enabling researchers to custom design and purchase thousands of research services in just a few mouse clicks

  December 11, 2017

   · 

  2 min read
• 

  Business

  Illumina Brings Aboard Tech Exec as New Chief People Officer

  Hoyt will start on January 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies.

  December 11, 2017

   · 

  3 min read